Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening

Table 5

Costs in both Chinese Renminbi, CNY (), and US dollar () and detected colorectal cancer (CRC) and advanced neoplasm by comparing double FITs to single FIT in the Jiashan mass CRC screening program in China, 2007–2009.

	FIT			Colonoscopy		CRC		Advanced neoplasm
	Participant	Total cost (/)	Positive	Participant	Total cost (/)	Number	Cost (/)/case	Number	Cost (/)/case
FIT1	24,375	195,000/30,675	1,148	926	250,020/39,330	33	13,485/2,121	103	4,321/680
FIT2	20,886	146,202/22,999	915	754	203,580/32,025	24	14,574/2,293	72	4,858/764
Both	20,842	312,630/49,179	301	250	67,500/10,618	18	21,118/3,322	48	7,919/1,246
Either	24,419	341,510/53,722	1,762	1,430	386,100/60,736	39	18,657/2,935	127	5,729/901
FIT2 only	20,886	146,202/22,999	614	504	136,080/21,406	6	47,047/7,401	24	11,762/1,850

FIT1, the first FIT; FIT2, the second FIT; FIT2 only refers to those who completed FIT2 without the completion of FIT1.
The currency exchange rate was 1.000 USD = 6.357 CNY at the time when the screening program was done.